An additive effect of protective host genetic factors correlates with HIV nonprogression status

Journal of Acquired Immune Deficiency Syndromes

Volumn 56, Issue 4, 2011, Pages 300-305

  Salgado, María ^a   Simón, Ainhoa ^a   Sanz Minguela, Beatriz ^a   Rallón, Norma Ibón ^a   López, Mariola ^a   Vicario, José Luis ^b   Benito, José Miguel ^a   Rodés, Berta ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b Centro de Transfusiones   (Spain)

Author keywords

genetic factors; HLA; LTNP; SNP

Indexed keywords

CHEMOKINE; CHEMOKINE CCL3L1; CHEMOKINE RECEPTOR CCR5; DNA; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALLELE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE DELETION; GENE DOSAGE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC RISK; GENOTYPE; HAPLOTYPE; HEREDITY; HLA TYPING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CHEMOKINES, CC; DISEASE PROGRESSION; FEMALE; GENOTYPE; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HLA ANTIGENS; HUMANS; IMMUNITY, INNATE; LEUKOCYTES, MONONUCLEAR; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; RECEPTORS, CCR5; SEQUENCE ANALYSIS, DNA;

EID: 79952452307     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3182036f14     Document Type: Article

References (39)

1. Alexander L, Weiskopf E, Greenough TC, et al. Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection. J Virol. 2000;74:4361-4376. (Pubitemid 30214444)
2. Li L, Li HS, Pauza CD, et al. Roles of HIV-1 auxiliary proteins in viral pathogenesis and host-pathogen interactions. Cell Res. 2005;15:923-934. (Pubitemid 41826262)
3. Kemal KS, Beattie T, Dong T, et al. Transition from long-term nonprogression to HIV-1 disease associated with escape from cellular immune control. J Acquir Immune Defic Syndr. 2008;48:119-126.
4. Zhang L, Huang Y, Yuan H, et al. Genetic characterization of vif, vpr, and vpu sequences from long-term survivors of human immunodeficiency virus type 1 infection. Virology. 1997;228:340-349. (Pubitemid 27238801)
5. Lama J, Planelles V. Host factors influencing susceptibility to HIV infection and AIDS progression. Retrovirology. 2007;4:52.
6. Saksena NK, Rodes B, Wang B, et al. Elite HIV controllers: myth or reality? AIDS Rev. 2007;9:195-207. (Pubitemid 351181618)
7. Fellay J, Shianna KV, Ge D, et al. A whole-genome association study of major determinants for host control of HIV-1. Science. 2007;317: 944-997.
8. Gonzalez E, Kulkarni H, Bolivar H, et al. The influence of CCL3L1 genecontaining segmental duplications on HIV-1/AIDS susceptibility. Science. 2005;307:1434-140.
9. Huang Y, Paxton WA, Wolinsky SM, et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med. 1996;2: 1240-1243. (Pubitemid 26375409)
10. Limou S, Le Clerc S, Coulonges C, et al. Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02). J Infect Dis. 2009; 199:419-426.
11. van Manen D, Kootstra NA, Boeser-Nunnink B, et al. Association of HLA-C and HCP5 gene regions with the clinical course of HIV-1 infection. AIDS. 2009;23:19-28.
12. Mungall AJ, Palmer SA, Sims SK, et al. The DNA sequence and analysis of human chromosome 6. Nature. 2003;425:805-811. (Pubitemid 37351459)
13. Marsh SGE, Parham P, Barber LD. The HLA FactsBook. London, United Kingdom: Academic Press; 2000.
14. Kaslow RA, Carrington M, Apple R, et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med. 1996;2:405-411. (Pubitemid 26193012)
15. Irving SG, Zipfel PF, Balke J, et al. Two inflammatory mediator cytokine genes are closely linked and variably amplified on chromosome 17q. Nucleic Acids Res. 1990;18:3261-3270.
16. Dolan MJ, Kulkarni H, Camargo JF, et al. CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms. Nat Immunol. 2007;8:1324-1336. (Pubitemid 350131170)
17. Rodes B, Toro C, Paxinos E, et al. Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection. AIDS. 2004;18:1109-1116. (Pubitemid 38738510)
18. Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature. 1996;382:722-725.
19. Townson JR, Barcellos LF, Nibbs RJB. Gene copy number regulates the production of the human chemokine CCL3-L1. Eur J Immunol. 2002;32: 3016-3026. (Pubitemid 35238195)
20. Stephens HAF. HIV-1 diversity versus HLA class I polymorphism. Trends Immunol. 2005;26:41-47.
21. Sidney J, Peters B, Frahm N, et al. HLA class I supertypes: a revised and updated classification. BMC Immunol. 2008;9:1.
22. Korber BTM, Brander C, Haynes BF, et al. HIV Molecular Immunology 2006/2007. Los Alamos, New Mexico: Los Alamos National Laboratory, Theoretical Biology and Biophysics; 2007.
23. Casado C, Colombo S, Rauch A, et al. Host and viral genetic correlates of clinical definitions of HIV-1 disease progression. PLoS ONE. 2010;5:e11079.
24. Migueles SA, Sabbaghian MS, Shupert WL, et al. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIVinfected long term nonprogressors. Proc Natl Acad Sci USA. 2000;97: 2709-2714. (Pubitemid 30159236)
25. Rosenberg ES, Billingsley JM, Caliendo AM, et al. Vigorous HIV-1- specific CD4+ T cell responses associated with control of viremia. Science. 1997;278:1447-1450. (Pubitemid 27509814)
26. Eskild A, Jonassen TO, Heger B, et al. The estimated impact of the CCR-5 delta32 gene deletion on HIV disease progression varies with study design. Oslo HIV Cohort Study Group. AIDS. 1998;12:2271-2274. (Pubitemid 28526405)
27. Morawetz RA, Rizzardi GP, Glauser D, et al. Genetic polymorphism of CCR5 gene and HIV disease: the heterozygous (CCR5/delta ccr5) genotype is neither essential nor sufficient for protection against disease progression. Swiss HIV Cohort. Eur J Immunol. 1997;27:3223-3227. (Pubitemid 28018018)
28. Schinkel J, LangendamMW, Coutinho RA, et al. No evidence for an effect of the CCR5 delta32/+ and CCR2b 64I/+ mutations on human immunodeficiency virus (HIV)-1 disease progression among HIV-1- infected injecting drug users. J Infect Dis. 1999;179:825-831. (Pubitemid 29159327)
29. Wilkinson DA, Operskalski EA, Busch MP, et al. A 32-bp deletion within the CCR5 locus protects against transmission of parenterally acquired human immunodeficiency virus but does not affect progression to AIDSdefining illness. J Infect Dis. 1998;178:1163-1166. (Pubitemid 28452215)
30. Hladik F, Liu H, Speelmon E, et al. Combined effect of CCR5-D32 heterozygosity and the CCR5 promoter polymorphism -2459 A/G on CCR5 expression and resistance to human immunodeficiency virus type 1 transmission. J Virol. 2005;79:11677-11684. (Pubitemid 41279286)
31. Nakajima T, Ohtani H, Naruse T, et al. Copy number variations of CCL3L1 and long-term prognosis of HIV-1 infection in asymptomatic HIV-infected Japanese with hemophilia. Immunogenetics. 2007;59: 793-798. (Pubitemid 47594105)
32. Trachtenberg E, Korber B, Sollars C, et al. Advantage of rare HLA supertype in HIV disease progression. Nat Med. 2003;9:928-935. (Pubitemid 36889937)
33. Hendel H, Caillat-Zucman S, Lebuanec H, et al. New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS. J Immunol. 1999;162:6942-6946. (Pubitemid 29309424)
34. Flores-Villanueva PO, Hendel H, Caillat-Zucman S, et al. Associations of MHC ancestral haplotypes with resistance/susceptibility to AIDS disease development. J Immunol. 2003;170:1925-1929. (Pubitemid 36197411)
35. Catano G, Kulkarni H, He W, et al. HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 alleles. PLoS ONE. 2008;3:e3636.
36. Kiepiela P, Leslie AJ, Honeyborne I, et al. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature. 2004; 432:769-775.
37. Matthews PC, Prendergast A, Leslie A, et al. Central role of reverting mutations in HLA associations with human immunodeficiency virus set point. J Virol. 2008;82:8548-559.
38. Trachtenberg E, Bhattacharya T, Ladner M, et al. The HLA-B/-C haplotype block contains major determinants for host control of HIV. Genes immune. 2009;10:673-677.
39. Fellay J, Ge D, Shianna KV, et al. The role of common human polymorphisms in HIV control. Presented at: 16th Conference of Retroviruses and Opportunistic Infections; February 8-11, 2009; Montreal, Canada. Abstract 542.